Christopher Borella
16Patents
3h-index
26Co-inventors
56Inventor score
Filing activity: Mar 19, 2002 → Oct 15, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7709518B2 | Compounds for inflammation and immune-related uses | Emerging Cross-Sectional Technologies | 30 | Active |
| US7572821B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 5 | Active |
| US6660741B2 | Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor | Human Necessities | 5 | Expired |
| US7781462B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 3 | Active |
| US8269017B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 3 | Active |
| US7884094B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 2 | Active |
| US8524756B2 | Compounds for inflammation and immune-related uses | Emerging Cross-Sectional Technologies | 2 | Active |
| US8680100B2 | Sulfonylhydrazide compounds for treating proliferative disorders | Chemistry; Metallurgy | 2 | Active |
| US6887887B2 | Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor | Human Necessities | 1 | Expired |
| US8058297B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 1 | Active |
| US8314134B2 | Compounds for inflammation and immune-related uses | Emerging Cross-Sectional Technologies | 1 | Active |
| US8501790B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 1 | Active |
| US8598366B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 0 | Active |
| US8399435B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 0 | Active |
| US9090603B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 0 | Active |
| US9175022B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.